Hippocampal and cortical atrophy in amyloid-negative mild cognitive impairments: Comparison with amyloid-positive mild cognitive impairment

Neurobiology of Aging

Volumn 35, Issue 2, 2014, Pages 291-300

  Ye, Byoung Seok ^a   Seo, Sang Won ^a   Kim, Chi Hun ^a   Jeon, Seun ^b   Kim, Geon Ha ^a   Noh, Young ^c   Cho, Hanna ^a   Yoon, Cindy W ^d   Kim, Hee Jin ^a   Jang, Eun Young ^a   Lee, Jeongmin ^a   Kim, Jung Hyun ^a   Chin, Juhee ^a   Lee, Jong Min ^b   Kim, Jeong Hun ^e   Seong, Joon kyung ^e   Kim, Chang Hun ^e   Choe, Yearn Seong ^a   Lee, Kyung Han ^a   Na, Duk L ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c Gachon University   (South Korea)

^d Inha University School of Medicine   (South Korea)

^e Korea University   (South Korea)

Author keywords

Alzheimer's disease; Cortical thickness; Hippocampus; Mild cognitive impairment; Pittsburgh compound B

Indexed keywords

AMYLOID PROTEIN; PITTSBURGH COMPOUND B;

ADULT; AGED; AMYLOID NEGATIVE MILD COGNITIVE IMPAIRMENT; AMYLOID POSITIVE MILD COGNITIVE IMPAIRMENT; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX ATROPHY; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); CORTICAL THINNING; FEMALE; HIPPOCAMPAL ATROPHY; HIPPOCAMPUS; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NERVOUS SYSTEM PARAMETERS; PATIENT CODING; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRECUNEUS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBICULUM; TEMPORAL LOBE; TEMPOROPARIETAL JUNCTION;

ALZHEIMER'S DISEASE; CORTICAL THICKNESS; HIPPOCAMPUS; MILD COGNITIVE IMPAIRMENT; PITTSBURGH COMPOUND B;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; ANILINE COMPOUNDS; ATROPHY; CEREBRAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RISK; THIAZOLES;

EID: 84887232865     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.08.017     Document Type: Article

References (47)

1. Aizenstein H.J., Nebes R.D., Saxton J.A., Price J.C., Mathis C.A., Tsopelas N.D., Ziolko S.K., James J.A., Snitz B.E., Houck P.R., Bi W., Cohen A.D., Lopresti B.J., DeKosky S.T., Halligan E.M., Klunk W.E. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch. Neurol. 2008, 65:1509-1517.
2. Alyassin A.M., Lancaster J.L., Downs J.H., Fox P.T. Evaluation of new algorithms for the interactive measurement of surface area and volume. Med. Phys. 1994, 21:741-752.
3. Bancher C., Egensperger R., Kosel S., Jellinger K., Graeber M.B. Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia. Acta. Neuropathol. 1997, 94:403-409.
4. Becker J.A., Hedden T., Carmasin J., Maye J., Rentz D.M., Putcha D., Fischl B., Greve D.N., Marshall G.A., Salloway S., Marks D., Buckner R.L., Sperling R.A., Johnson K.A. Amyloid-beta associated cortical thinning in clinically normal elderly. Ann. Neurol. 2011, 69:1032-1042.
5. Becker J.T., Davis S.W., Hayashi K.M., Meltzer C.C., Toga A.W., Lopez O.L., Thompson P.M., Imaging Methods and Analysis in Geriatrics Research Group Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. Arch. Neurol. 2006, 63:97-101.
6. Bennett D.A., Schneider J.A., Bienias J.L., Evans D.A., Wilson R.S. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005, 64:834-841.
7. Chan D., Fox N.C., Scahill R.I., Crum W.R., Whitwell J.L., Leschziner G., Rossor A.M., Stevens J.M., Cipolotti L., Rossor M.N. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann. Neurol. 2001, 49:433-442.
8. Csernansky J.G., Wang L., Joshi S., Miller J.P., Gado M., Kido D., McKeel D., Morris J.C., Miller M.I. Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology 2000, 55:1636-1643.
9. Csernansky J.G., Wang L., Swank J., Miller J.P., Gado M., McKeel D., Miller M.I., Morris J.C. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage 2005, 25:783-792.
10. den Heijer T., Launer L.J., Prins N.D., van Dijk E.J., Vermeer S.E., Hofman A., Koudstaal P.J., Breteler M.M. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology 2005, 64:263-267.
11. Dickerson B.C., Bakkour A., Salat D.H., Feczko E., Pacheco J., Greve D.N., Grodstein F., Wright C.I., Blacker D., Rosas H.D., Sperling R.A., Atri A., Growdon J.H., Hyman B.T., Morris J.C., Fischl B., Buckner R.L. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb. Cortex 2009, 19:497-510.
12. Du A.T., Schuff N., Laakso M.P., Zhu X.P., Jagust W.J., Yaffe K., Kramer J.H., Miller B.L., Reed B.R., Norman D., Chui H.C., Weiner M.W. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology 2002, 58:1635-1641.
13. Egger K., Schocke M., Weiss E., Auffinger S., Esterhammer R., Goebel G., Walch T., Mechtcheriakov S., Marksteiner J. Pattern of brain atrophy in elderly patients with depression revealed by voxel-based morphometry. Psychiatry Res. 2008, 164:237-244.
14. Frisoni G.B., Ganzola R., Canu E., Rub U., Pizzini F.B., Alessandrini F., Zoccatelli G., Beltramello A., Caltagirone C., Thompson P.M. Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla. Brain 2008, 131:3266-3276.
15. Gerardin E., Chetelat G., Chupin M., Cuingnet R., Desgranges B., Kim H.S., Niethammer M., Dubois B., Lehericy S., Garnero L., Eustache F., Colliot O. Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging. Neuroimage 2009, 47:1476-1486.
16. Goldstein I.B., Bartzokis G., Guthrie D., Shapiro D. Ambulatory blood pressure and brain atrophy in the healthy elderly. Neurology 2002, 59:713-719.
17. Hogan R.E., Bucholz R.D., Joshi S. Hippocampal deformation-based shape analysis in epilepsy and unilateral mesial temporal sclerosis. Epilepsia 2003, 44:800-806.
18. Iseki E., Yamamoto R., Murayama N., Minegishi M., Togo T., Katsuse O., Kosaka K., Akiyama H., Tsuchiya K., de Silva R., Andrew L., Arai H. Immunohistochemical investigation of neurofibrillary tangles and their tau isoforms in brains of limbic neurofibrillary tangle dementia. Neurosci. Lett. 2006, 405:29-33.
19. Jellinger K.A., Attems J. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol. 2007, 113:107-117.
20. Jeon S., Yoon U., Park J.-S., Seo S.W., Kim J.-H., Kim S.T., Kim S.I., Na D.L., Lee J.-M. Fully automated pipeline for quantification and localization of white matter hyperintensity in brain magnetic resonance image. Int. J. Imaging Syst. Technol. 2011, 21:193-200.
21. Jung I.K., Kwak D.I., Shin D.K., Lee M.S., Lee H.S., Kim J.Y. AReliability and Validity Study of Geriatric Depression Scale. J.Korean Neuropsychiatr. Assoc. 1997, 36:103-112.
22. Kim G.H., Kim J., Seoung J.K., Lee J.H., Seo S.W., Shin J.S., Kim C.H., Cho H., Noh Y., Kim J.S., Oh S.J., Na D.L. Hippocampal volume and shape analysis in patients with PiB (-), PiB (+) subcortical vascular dementia and Alzheimer's disease. Alzheimer Dement. 2012, 8(Supplement):P158.
23. Kim H., Yoon C., Noh Y., Cho H., Kim G.H., Ye B.S., Jeon S., Lee J.M., Kim J., Seong J.K., Choe Y.S., Lee K., Park S.E., Kim C., Lee J.H., Weiner M., Na D.L., Seo S.W. Cognition, cortical thickness and hippocampal shape in pure vascular mild cognitive impairment and dementia. Alzheimer Dement. 2013, (Supplement):P123.
24. Kizilbash A.H., Vanderploeg R.D., Curtiss G. The effects of depression and anxiety on memory performance. Arch. Clin. Neuropsychol. 2002, 17:57-67.
25. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55:306-319.
26. Knopman D., Boland L.L., Mosley T., Howard G., Liao D., Szklo M., McGovern P., Folsom A.R. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001, 56:42-48. Atherosclerosis Risk in Communities Study Investigators.
27. Kondo T., Asai M., Tsukita K., Kutoku Y., Ohsawa Y., Sunada Y., Imamura K., Egawa N., Yahata N., Okita K., Takahashi K., Asaka I., Aoi T., Watanabe A., Watanabe K., Kadoya C., Nakano R., Watanabe D., Maruyama K., Hori O., Hibino S., Choshi T., Nakahata T., Hioki H., Kaneko T., Naitoh M., Yoshikawa K., Yamawaki S., Suzuki S., Hata R., Ueno S., Seki T., Kobayashi K., Toda T., Murakami K., Irie K., Klein W.L., Mori H., Asada T., Takahashi R., Iwata N., Yamanaka S., Inoue H. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness. Cell Stem Cell 2013, 12:487-496.
28. Lee J.H., Kim S.H., Kim G.H., Seo S.W., Park H.K., Oh S.J., Kim J.S., Cheong H.K., Na D.L. Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. Neurology 2011, 77:18-25.
29. Lindberg O., Walterfang M., Looi J.C., Malykhin N., Ostberg P., Zandbelt B., Styner M., Paniagua B., Velakoulis D., Orndahl E., Wahlund L.O. Hippocampal shape analysis in Alzheimer's disease and frontotemporal lobar degeneration subtypes. J.Alzheimer Dis. 2012, 30:355-365.
30. Maillard P., Seshadri S., Beiser A., Himali J.J., Au R., Fletcher E., Carmichael O., Wolf P.A., Decarli C. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol. 2012, 11:1039-1047.
31. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H., Berg L. Mild cognitive impairment represents early-stage Alzheimer disease. Arch. Neurol. 2001, 58:397-405.
32. Petersen R.C., Parisi J.E., Dickson D.W., Johnson K.A., Knopman D.S., Boeve B.F., Jicha G.A., Ivnik R.J., Smith G.E., Tangalos E.G., Braak H., Kokmen E. Neuropathologic features of amnestic mild cognitive impairment. Arch. Neurol. 2006, 63:665-672.
33. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56:303-308.
34. Pike K.E., Savage G., Villemagne V.L., Ng S., Moss S.A., Maruff P., Mathis C.A., Klunk W.E., Masters C.L., Rowe C.C. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 2007, 130:2837-2844.
35. Raz N., Rodrigue K.M., Acker J.D. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. Behav. Neurosci. 2003, 117:1169-1180.
36. Rentz D.M., Locascio J.J., Becker J.A., Moran E.K., Eng E., Buckner R.L., Sperling R.A., Johnson K.A. Cognition, reserve, and amyloid deposition in normal aging. Ann. Neurol. 2010, 67:353-364.
37. Rowe C.C., Ng S., Ackermann U., Gong S.J., Pike K., Savage G., Cowie T.F., Dickinson K.L., Maruff P., Darby D., Smith C., Woodward M., Merory J., Tochon-Danguy H., O'Keefe G., Klunk W.E., Mathis C.A., Price J.C., Masters C.L., Villemagne V.L. Imaging beta-amyloid burden in aging and dementia. Neurology 2007, 68:1718-1725.
38. Sabattoli F., Boccardi M., Galluzzi S., Treves A., Thompson P.M., Frisoni G.B. Hippocampal shape differences in dementia with Lewy bodies. Neuroimage 2008, 41:699-705.
39. Schneider J.A., Arvanitakis Z., Leurgans S.E., Bennett D.A. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann. Neurol. 2009, 66:200-208.
40. Seo S.W., Im K., Lee J.M., Kim Y.H., Kim S.T., Kim S.Y., Yang D.W., Kim S.I., Cho Y.S., Na D.L. Cortical thickness in single- versus multiple-domain amnestic mild cognitive impairment. Neuroimage 2007, 36:289-297.
41. Singh V., Chertkow H., Lerch J.P., Evans A.C., Dorr A.E., Kabani N.J. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. Brain 2006, 129:2885-2893.
42. Tosun D., Joshi S., Weiner M.W. Neuroimaging predictors of brain amyloidosis in mild cognitive impairment. Ann. Neurol 2013, Accessed on July 25, 2013. 10.1002/ana.23921.
43. Wang L., Miller J.P., Gado M.H., McKeel D.W., Rothermich M., Miller M.I., Morris J.C., Csernansky J.G. Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type. Neuroimage 2006, 30:52-60.
44. Wolk D.A., Price J.C., Saxton J.A., Snitz B.E., James J.A., Lopez O.L., Aizenstein H.J., Cohen A.D., Weissfeld L.A., Mathis C.A., Klunk W.E., De-Kosky S.T. Amyloid imaging in mild cognitive impairment subtypes. Ann. Neurol. 2009, 65:557-568.
45. Worsley K.J., Marrett S., Neelin P., Vandal A.C., Friston K.J., Evans A.C. Aunified statistical approach for determining significant signals in images of cerebral activation. Hum. Brain Mapp. 1996, 4:58-73.
46. Yuan Y., Zhu W., Zhang Z., Bai F., Yu H., Shi Y., Qian Y., Liu W., Jiang T., You J., Liu Z. Regional gray matter changes are associated with cognitive deficits in remitted geriatric depression: an optimized voxel-based morphometry study. Biol. Psychiatry 2008, 64:541-544.
47. Zarow C., Sitzer T.E., Chui H.C. Understanding hippocampal sclerosis in the elderly: epidemiology, characterization, and diagnostic issues. Curr. Neurol. Neurosci. Rep. 2008, 8:363-370.